Amy B. Heimberger

机构：Northwestern University, Midwestern University, University of Chicago, Northwestern University, Northwestern Medicine, Neurological Surgery, Robert H. Lurie Comprehensive Cancer Center of Northwestern University · ORCID：0000-0002-9970-8695

发表论文 711 篇 · 总被引 31503 次 · h-index 89

代表论文

• Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells (2026 · Nature · 被引 5)
• Data from Phase I Evaluation of Patients with Newly Diagnosed Glioblastoma Treated with Radiation, Nivolumab, and IDO1 Enzyme Inhibitor BMS-986205 (2026)
• Supplementary Figures1 from Phase I Evaluation of Patients with Newly Diagnosed Glioblastoma Treated with Radiation, Nivolumab, and IDO1 Enzyme Inhibitor BMS-986205 (2026)
• Supplementary Tables1 from Phase I Evaluation of Patients with Newly Diagnosed Glioblastoma Treated with Radiation, Nivolumab, and IDO1 Enzyme Inhibitor BMS-986205 (2026)
• Data Source1 from Phase I Evaluation of Patients with Newly Diagnosed Glioblastoma Treated with Radiation, Nivolumab, and IDO1 Enzyme Inhibitor BMS-986205 (2026)
• Myeloid-targeted RNA nanotherapeutics rewire cholesterol metabolism to unleash anti-tumor immunity in glioblastoma (2026 · bioRxiv (Cold Spring Harbor Laboratory))